<DOC>
	<DOC>NCT01102114</DOC>
	<brief_summary>The purpose of this study is to evaluate NicVAX as an aid to smoking cessation for long term abstinence.</brief_summary>
	<brief_title>A Second Study of NicVAX/Placebo as an Aid for Smoking Cessation</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Current smoker who smokes at least 10 cigarettes a day during the past year and wants to quit smoking. Smokers who are in good general health. Prior exposure to NicVAX or any other nicotine vaccine. Use of systemic steroids. Cancer or cancer treatment in the last 5 years. HIV infection. History of drug or alcohol abuse or dependence within 12 months. Significant cardiovascular, hepatic, renal, psychiatric and/or respiratory disease. Inability to fulfill all visits for approximately 52 weeks.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Smoking Cessation</keyword>
	<keyword>NicVAX</keyword>
	<keyword>Smoking Vaccine</keyword>
	<keyword>Smoking Abstinence</keyword>
	<keyword>Smoking</keyword>
	<keyword>Tobacco Cessation</keyword>
</DOC>